Ryan Zimmerman
Stock Analyst at BTIG
(4.14)
# 460
Out of 4,896 analysts
179
Total ratings
52.32%
Success rate
12.49%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Downgrades: Neutral | n/a | $8.00 | - | 5 | Jul 9, 2025 | |
| GMED Globus Medical | Downgrades: Neutral | n/a | $57.12 | - | 15 | May 27, 2025 | |
| VCEL Vericel | Maintains: Buy | $56 → $66 | $39.93 | +65.29% | 8 | Nov 26, 2024 | |
| PEN Penumbra | Maintains: Buy | $232 → $270 | $237.94 | +13.47% | 19 | Nov 26, 2024 | |
| GKOS Glaukos | Maintains: Buy | $140 → $149 | $103.81 | +43.53% | 10 | Nov 26, 2024 | |
| ISRG Intuitive Surgical | Maintains: Buy | $535 → $561 | $512.06 | +9.56% | 17 | Nov 26, 2024 | |
| SYK Stryker | Maintains: Buy | $383 → $394 | $389.46 | +1.17% | 15 | Oct 30, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $2.31 | +332.90% | 4 | Oct 18, 2024 | |
| ALC Alcon | Maintains: Buy | $104 → $106 | $87.48 | +21.17% | 11 | Oct 14, 2024 | |
| IART Integra LifeSciences Holdings | Upgrades: Neutral | n/a | $12.59 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $134 → $126 | $93.79 | +34.34% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $75.13 | +33.10% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $73.80 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $17.38 | +204.95% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.66 | +358.02% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.00 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.70 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.86 | +39.86% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.30 | +39.53% | 6 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.09 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $59 → $52 | $21.94 | +137.01% | 7 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.04 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $9.96 | +181.12% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $162.94 | +22.74% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $289.32 | +20.97% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $130 | $132.02 | -1.53% | 3 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $56.65 | - | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $89.92 | +42.35% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $13.04 | +15.03% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $65.72 | +38.47% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $20.07 | +109.27% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $6.88 | +663.08% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.89 | - | 3 | Apr 2, 2020 |
RxSight
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $8.00
Upside: -
Globus Medical
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $57.12
Upside: -
Vericel
Nov 26, 2024
Maintains: Buy
Price Target: $56 → $66
Current: $39.93
Upside: +65.29%
Penumbra
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $237.94
Upside: +13.47%
Glaukos
Nov 26, 2024
Maintains: Buy
Price Target: $140 → $149
Current: $103.81
Upside: +43.53%
Intuitive Surgical
Nov 26, 2024
Maintains: Buy
Price Target: $535 → $561
Current: $512.06
Upside: +9.56%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $389.46
Upside: +1.17%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $2.31
Upside: +332.90%
Alcon
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $87.48
Upside: +21.17%
Integra LifeSciences Holdings
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $12.59
Upside: -
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $93.79
Upside: +34.34%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $75.13
Upside: +33.10%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $73.80
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $17.38
Upside: +204.95%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.66
Upside: +358.02%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.00
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.70
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $2.86
Upside: +39.86%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $4.30
Upside: +39.53%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $8.09
Upside: -
Oct 4, 2023
Maintains: Buy
Price Target: $59 → $52
Current: $21.94
Upside: +137.01%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $11.04
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $9.96
Upside: +181.12%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $162.94
Upside: +22.74%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $289.32
Upside: +20.97%
Apr 17, 2023
Maintains: Buy
Price Target: $125 → $130
Current: $132.02
Upside: -1.53%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $56.65
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $89.92
Upside: +42.35%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $13.04
Upside: +15.03%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $65.72
Upside: +38.47%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $20.07
Upside: +109.27%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $6.88
Upside: +663.08%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $11.89
Upside: -